Brenntag AG (OTCMKTS:BNTGY - Get Free Report) was the target of a significant decline in short interest in July. As of July 31st, there was short interest totaling 12,781 shares, a decline of 41.4% from the July 15th total of 21,822 shares. Based on an average daily volume of 52,119 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the shares of the stock are sold short.
Brenntag Stock Performance
Brenntag stock opened at $14.15 on Monday. The stock has a 50-day moving average price of $13.24 and a two-hundred day moving average price of $13.08. Brenntag has a 12 month low of $10.19 and a 12 month high of $14.97. The company has a market capitalization of $10.21 billion, a PE ratio of 23.98 and a beta of 0.62.
Brenntag (OTCMKTS:BNTGY - Get Free Report) last released its quarterly earnings results on Wednesday, August 12th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.04. The company had revenue of $4.96 billion for the quarter, compared to analysts' expectations of $4.66 billion. Brenntag had a return on equity of 8.34% and a net margin of 2.41%. As a group, analysts predict that Brenntag will post 0.8 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research firms have weighed in on BNTGY. Deutsche Bank Aktiengesellschaft cut Brenntag from a "buy" rating to a "hold" rating in a research note on Tuesday, June 16th. Morgan Stanley reissued an "underweight" rating on shares of Brenntag in a report on Friday. UBS Group upgraded Brenntag from a "sell" rating to a "neutral" rating in a research report on Thursday, April 30th. Jefferies Financial Group upgraded Brenntag from a "moderate sell" rating to a "hold" rating in a research report on Wednesday, May 20th. Finally, DZ Bank raised Brenntag from a "strong sell" rating to a "hold" rating in a research note on Monday, July 27th. Eight equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Reduce" and an average price target of $12.80.
Check Out Our Latest Analysis on Brenntag
Brenntag Company Profile
(
Get Free Report)
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Brenntag, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brenntag wasn't on the list.
While Brenntag currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.